HPV-16 E2 Physical Status and Molecular Evolution in Vivo in Cervical Carcinomas
The International Journal of Biological Markers · 2014-01 · 29 (1) · e78-e85
DOI: 10.5301/jbm.5000051 ↗Kurz gefasst
Fachartikel in der Zeitschrift The International Journal of Biological Markers, online erschienen am 03.04.2018. Verfasst von Saloua Kahla und 4 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Immunology Microbiology Environmental and Carcinogenesis (IMEC), Science Faculty of Bizerte, University of Carthage, 7021 Jarzouna, Bizerte -…. Hauptthemen laut MEDLINE: Evolution, Molecular. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 41 Literaturangaben.
Abstract (Originalsprache)
A key event in the development of cervical carcinoma is the deregulated expression of high-risk human papillomavirus (HR-HPV) oncogenes, most commonly due to HPV integration into host DNA. Here we explored whether HPV-16 E2 gene integrity is a biomarker of progressive disease with oncogenes expression. HPV-16 genome disruption was assessed by amplification of the entire E2 gene, while mRNA expression patterns of the E1, E2, E6, and E7 genes were evaluated by reverse transcription PCR (RT-PCR). As expected, E2 disruption was significantly higher among patients with cervical cancers than subjects with benign lesions (p=0.02). The status of the E2 gene correlated with tumorogenesis, and seemed also to correlate with the stage of the carcinomas, since integrated HPV-16 DNA was frequently detected in patients with advanced cancer stages (75% of stage III vs 60% stages I and II). In bivariate analysis, the lesions’ grade was most significantly associated with HPV-16 DNA disruption (p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Unit of Immunology Microbiology Environmental and Carcinogenesis (IMEC), Science Faculty of Bizerte, University of Carthage, 7021 Jarzouna, Bizerte - Tunisia.
Zitieren
APA
Kahla, S., Kochbati, L., Chanoufi, M. B., Maalej, M., & Oueslati, R. (2014). HPV-16 E2 Physical Status and Molecular Evolution in Vivo in Cervical Carcinomas. The International Journal of Biological Markers, 29(1), e78-e85. https://doi.org/10.5301/jbm.5000051
Vancouver
Kahla S, Kochbati L, Chanoufi MB, Maalej M, Oueslati R. HPV-16 E2 Physical Status and Molecular Evolution in Vivo in Cervical Carcinomas. The International Journal of Biological Markers. 2014;29(1):e78-e85. doi:10.5301/jbm.5000051
BibTeX
@article{Kahla2014,
author = {Kahla, Saloua and Kochbati, Lotfi and Chanoufi, Mohamed Badis and Maalej, Mongi and Oueslati, Ridha},
title = {HPV-16 E2 Physical Status and Molecular Evolution in Vivo in Cervical Carcinomas},
journal = {The International Journal of Biological Markers},
year = {2014},
volume = {29},
number = {1},
pages = {e78--e85},
doi = {10.5301/jbm.5000051}
}
EUVIMED